Literature DB >> 33394457

Rewinding sarcopenia: a narrative review on the renin-angiotensin system.

Timur Ekiz1, Murat Kara2, Ayşe Merve Ata3, Vincenzo Ricci4, Özgür Kara5, Fırat Özcan6, Levent Özçakar2.   

Abstract

BACKGROUND AND AIMS: The purpose of this review was two-fold. First, we aimed to provide an in-depth glance on the relationship between renin-angiotensin system (RAS) dysregulation and sarcopenia. Second, we aimed to touch upon potential treatments of sarcopenia (including RAS blockers, vitamin D, and exercise) in light of the pertinent literature.
METHODS: Currently available research regarding the effects of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers on knee extensor strength, grip strength, chair stand test, gate speed together with the effects of exercise on muscle mass, strength, physical performance, blood pressure and cognitive tests (particularly in older adults) was reviewed.
RESULTS: Although some studies have shown favorable effects of ACEIs on muscle strength and/or physical function tests, some studies have reported no/negative association in between. The favorable impact of exercise on reducing blood pressure is shown, and exercise treatment is widely recommended in the relevant literature. Different types of exercises (aerobic, resistance, dancing, music movement, water-based, golf, knitting activities or multicomponent exercises) have shown improvement in cognitive functions as well.
CONCLUSION: Classical RAS activity results in deleterious effects not only on the cardiovascular but also on the neuromusculoskeletal system. Therefore, treatments targeting inhibition of the classical RAS activity seem to be important in the management of several age-related pathologies, including sarcopenia. As such, ACEIs, vitamin D, exercise, and healthy diet can have prominent effects not only on the modulation of RAS but also on physical and cognitive functions and sarcopenia as well.

Entities:  

Keywords:  Angiotensin-converting enzyme; Cognition; Exercise; Hypertension; Vitamin D

Year:  2021        PMID: 33394457     DOI: 10.1007/s40520-020-01761-3

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  78 in total

Review 1.  New therapeutic pathways in the RAS.

Authors:  Michael Bader; Robson A Santos; Thomas Unger; U Muscha Steckelings
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-12       Impact factor: 1.636

2.  Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia.

Authors:  Tyesha N Burks; Eva Andres-Mateos; Ruth Marx; Rebeca Mejias; Christel Van Erp; Jessica L Simmers; Jeremy D Walston; Christopher W Ward; Ronald D Cohn
Journal:  Sci Transl Med       Date:  2011-05-11       Impact factor: 17.956

3.  Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.

Authors:  Yao-Hua Song; Yangxin Li; Jie Du; William E Mitch; Nadia Rosenthal; Patrick Delafontaine
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

4.  Angiotensin-(1-7) Prevents Skeletal Muscle Atrophy Induced by Transforming Growth Factor Type Beta (TGF-β) via Mas Receptor Activation.

Authors:  Johanna Ábrigo; Felipe Simon; Daniel Cabrera; Claudio Cabello-Verrugio
Journal:  Cell Physiol Biochem       Date:  2016-11-14

5.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.

Authors:  Clara K Chow; Koon K Teo; Sumathy Rangarajan; Shofiqul Islam; Rajeev Gupta; Alvaro Avezum; Ahmad Bahonar; Jephat Chifamba; Gilles Dagenais; Rafael Diaz; Khawar Kazmi; Fernando Lanas; Li Wei; Patricio Lopez-Jaramillo; Lu Fanghong; Noor Hassim Ismail; Thandi Puoane; Annika Rosengren; Andrzej Szuba; Ahmet Temizhan; Andy Wielgosz; Rita Yusuf; Afzalhussein Yusufali; Martin McKee; Lisheng Liu; Prem Mony; Salim Yusuf
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

6.  Fibrotic response induced by angiotensin-II requires NAD(P)H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells.

Authors:  Claudio Cabello-Verrugio; María José Acuña; María Gabriela Morales; Alvaro Becerra; Felipe Simon; Enrique Brandan
Journal:  Biochem Biophys Res Commun       Date:  2011-06-12       Impact factor: 3.575

Review 7.  Renin-angiotensin system: an old player with novel functions in skeletal muscle.

Authors:  Claudio Cabello-Verrugio; María Gabriela Morales; Juan Carlos Rivera; Daniel Cabrera; Felipe Simon
Journal:  Med Res Rev       Date:  2015-03-11       Impact factor: 12.944

Review 8.  Renin-angiotensin system and cardiovascular risk.

Authors:  Roland E Schmieder; Karl F Hilgers; Markus P Schlaich; Bernhard M W Schmidt
Journal:  Lancet       Date:  2007-04-07       Impact factor: 79.321

9.  Detrimental Effects of Centrally Administered Angiotensin II are Enhanced in a Mouse Model of Alzheimer Disease Independently of Blood Pressure.

Authors:  Koki Takane; Yu Hasegawa; Bowen Lin; Nobutaka Koibuchi; Cheng Cao; Takashi Yokoo; Shokei Kim-Mitsuyama
Journal:  J Am Heart Assoc       Date:  2017-04-20       Impact factor: 5.501

10.  Sarcopenia is associated with hypertension in older adults: a systematic review and meta-analysis.

Authors:  Tingting Bai; Fang Fang; Feika Li; Yan Ren; Jiaan Hu; Jiumei Cao
Journal:  BMC Geriatr       Date:  2020-08-06       Impact factor: 3.921

View more
  5 in total

Review 1.  Vitamin D Deficiency in Older Patients-Problems of Sarcopenia, Drug Interactions, Management in Deficiency.

Authors:  Małgorzata Kupisz-Urbańska; Paweł Płudowski; Ewa Marcinowska-Suchowierska
Journal:  Nutrients       Date:  2021-04-10       Impact factor: 5.717

2.  Serum 25-hydroxy vitamin D and the risk of low muscle mass in young and middle-aged Korean adults.

Authors:  Yejin Kim; Yoosoo Chang; Seungho Ryu; In Young Cho; Min-Jung Kwon; Sarah H Wild; Christopher D Byrne
Journal:  Eur J Endocrinol       Date:  2022-03-08       Impact factor: 6.664

3.  Cross-sectional area of erector spinae muscles is associated with activities of daily living at discharge in middle- to older-aged patients with coronavirus disease 2019.

Authors:  Masashi Yamashita; Tomotaka Koike; Nobuaki Hamazaki; Kensuke Ueno; Shota Uchida; Takumi Noda; Ken Ogura; Daina Nagumo; Takashi Miki; Saki Shakuta; Tatsuhiko Wada; Kentaro Kamiya
Journal:  Exp Gerontol       Date:  2022-03-25       Impact factor: 4.253

4.  Is Physical Activity an Effective Factor for Modulating Pressure Pain Threshold and Pain Tolerance after Cardiovascular Incidents?

Authors:  Katarzyna Leźnicka; Maciej Pawlak; Agnieszka Maciejewska-Skrendo; Jacek Buczny; Anna Wojtkowska; Grzegorz Pawlus; Anna Machoy-Mokrzyńska; Aleksandra Jażdżewska
Journal:  Int J Environ Res Public Health       Date:  2022-09-08       Impact factor: 4.614

5.  Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM.

Authors:  Murat Kara; Bayram Kaymak; Walter Frontera; Ayşe Merve Ata; Vincenzo Ricci; Timur Ekiz; Ke-Vin Chang; Der-Sheng Han; Xanthi Michail; Michael Quittan; Jae-Young Lim; Jonathan F Bean; Franco Franchignoni; Levent Özçakar
Journal:  J Rehabil Med       Date:  2021-06-21       Impact factor: 2.912

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.